Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,898 | 60,108 | 53,038 | 23,461 | 31,836 |
| Marketable Securities | 319,074 | 196,170 | 222,967 | 265,777 | 300,535 |
| Receivables | 39,879 | 66,955 | 66,821 | 74,007 | 64,652 |
| Inventories | 24,968 | 24,172 | 29,270 | 31,421 | 39,032 |
| TOTAL | $479,064 | $364,147 | $380,835 | $406,205 | $447,248 |
| Non-Current Assets | |||||
| PPE Net | 19,618 | 16,315 | 17,910 | 16,267 | 14,677 |
| Other Non-Current Assets | 14,100 | 12,500 | 12,921 | 13,322 | 254 |
| TOTAL | $33,718 | $28,815 | $30,831 | $29,589 | $14,931 |
| Total Assets | $512,782 | $392,962 | $411,666 | $435,794 | $462,179 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,758 | 1,627 | 7,997 | 10,811 | 16,863 |
| Accrued Expenses | 49,862 | 36,207 | 34,365 | 30,242 | 37,867 |
| TOTAL | $96,705 | $96,737 | $95,056 | $92,257 | $92,019 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12,242 | 10,783 | 11,251 | 11,723 | 0 |
| TOTAL | $12,242 | $10,783 | $11,251 | $11,723 | $N/A |
| Total Liabilities | $108,947 | $107,520 | $106,307 | $103,980 | $92,019 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 90,374 | 90,051 | 79,816 | 79,070 | 78,182 |
| Common Shares | 903 | 800 | 798 | 789 | 782 |
| Retained earnings | -1,165,470 | -1,107,550 | -1,073,955 | -1,023,733 | -960,721 |
| Other shareholders' equity | 85 | 103 | 148 | 36 | -87 |
| TOTAL | $403,835 | $285,442 | $305,359 | $331,814 | $370,160 |
| Total Liabilities And Equity | $512,782 | $392,962 | $411,666 | $435,794 | $462,179 |